Back to search
FDAFDA · Food and drugs·Recall number D-1092-2020

fentaNYL Citrate Injection, 50 mcg per mL, 250 mcg per 5 mL 5 mL syringe, For IV Use, Rx Only, PharMEDium Services, LLC 36 Stutte Road Dayton, NJ. NDC 61553-306-33

Published April 15, 2020 · Recall initiated: March 16, 2020

Summary

FDA records drug Class II recall D-1092-2020, published April 15, 2020 and initiated March 16, 2020. Recalling firm: PharMEDium Services, LLC; Status: Terminated; Reported quantity: 75 units; Lot: 193530007D, Exp 3/19/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Firm is recalling 46 lots of various products because of a lack of sterility assurance.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
PharMEDium Services, LLC
Distributor
Distributed Nationwide in the US
Lot
193530007D, Exp 3/19/2020
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was fentaNYL Citrate Injection, 50 mcg per mL, 250 mcg per 5 mL 5 mL syringe, For IV Use, Rx Only, PharMEDium Services, LLC 36 Stutte Road Dayton, NJ. NDC 61553-306-33 recalled?

Yes. FDA published recall D-1092-2020 on April 15, 2020. Reported hazard: Firm is recalling 46 lots of various products because of a lack of sterility assurance.

What should I do if I have this product?

Voluntary: Firm initiated · Letter